Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer
β¦ LIBER β¦
A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma
β Scribed by Jean L. Grem; Nanette McAtee; Frank Balis; Robert Murphy; David Venzon; Barnett Kramer; Barry Goldspiel; Martin Begley; Carmen J. Allegra
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 594 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A phase II trial of weekly high dose con
β
Enrique Aranda; AndrΓ©s Cervantes; Javier Dorta; Esperanza Blanco; Carlos FernΓ‘nd
π
Article
π
1995
π
John Wiley and Sons
π
English
β 419 KB
π 2 views
A phase II trial of continuous infusion
β
Masafumi Ikeda; Takuji Okusaka; Hideki Ueno; Yoriko Takezako; Chigusa Morizane
π
Article
π
2005
π
John Wiley and Sons
π
English
β 97 KB
A phase II study of outpatient chemother
β
Kwan H. Chi; Wing K. Chan; Dennis L. Cooper; Sang H. Yen; Ching Z. Lin; Kuang Y.
π
Article
π
1994
π
John Wiley and Sons
π
English
β 561 KB
Fluorodeoxyuridine with continuous leuco
β
Robert D. Levin; John H. Gordon
π
Article
π
1993
π
John Wiley and Sons
π
English
β 640 KB
Phase II study of oral eniluracil, 5-flu
β
Neal J. Meropol; Donna Niedzwiecki; Donna Hollis; Richard L. Schilsky; Robert J.
π
Article
π
2001
π
John Wiley and Sons
π
English
β 107 KB
π 3 views
Continuous infusion 5-fluorouracil plus
β
Harvey Rothman; James E. Cantrell; Jacob Lokich; Santo Difino; Jimmie Harvey; Ja
π
Article
π
1991
π
John Wiley and Sons
π
English
β 450 KB
Fifty-six previously untreated patients with biopsy-proven, locally advanced or metastatic and measurable adenocarcinoma of the pancreas were treated with the combination of a protracted intravenous infusion of 5-fluorouracil (5-FU) and low dose weekly bolus cisplatin administered continuously for 1